Next Article in Journal
In Vitro Antioxidant Activity of Idebenone Derivative-Loaded Solid Lipid Nanoparticles
Next Article in Special Issue
Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target
Previous Article in Journal
Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors
Previous Article in Special Issue
Functional Mitochondria Are Important for the Effect of Resveratrol
Open AccessFeature PaperReview

Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells

Laboratory of Translational Research, Arcispedale S. Maria Nuova IRCCS, Viale Risorgimento 80, 42124 Reggio Emilia, Italy
*
Author to whom correspondence should be addressed.
Academic Editors: Norbert Latruffe, Ole Vang and Dominique Vervandier-Fasseur
Molecules 2017, 22(6), 885; https://doi.org/10.3390/molecules22060885
Received: 28 April 2017 / Revised: 24 May 2017 / Accepted: 25 May 2017 / Published: 27 May 2017
(This article belongs to the Special Issue Improvements for Resveratrol Efficacy)
Resveratrol (RSV) is a well known chemopreventive molecule featuring anti-cancer properties. Our paper describes the main molecular targets of RSV linked to its antiproliferative activity on lymphoma and leukemia experimental models. It discusses further the most recent and most promising among these molecular targets for a translational application. View Full-Text
Keywords: resveratrol; lymphoma; leukemia; molecular target resveratrol; lymphoma; leukemia; molecular target
Show Figures

Figure 1

MDPI and ACS Style

Frazzi, R.; Guardi, M. Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells. Molecules 2017, 22, 885.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop